Equity Profile
Pre-Earnings Brief
Sotera Health Co (SHC) operates in the health care sector, specifically within life sciences tools and services. The company plays a crucial role in providing sterilization and lab services, which are essential for ensuring the safety and efficacy of medical products.
EPS
Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.
Revenue
Revenue figures provide insight into the company's sales performance and overall market demand for its services.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
5Q
EPS Beat Rate
88%
Avg EPS Surprise
+54.61%
Avg Stock Reaction
+2.03%
In Q4-2025, Sotera Health reported an impressive EPS of $0.86, significantly beating estimates. However, the stock fell by 4.40% the following day, indicating market skepticism despite strong earnings.
Management Promises & Guidance
Analysts expect Sotera Health to maintain its strong earnings trajectory with a consensus EPS of $0.17 and revenue of $271M. The market is keen to see if the company can continue its streak of earnings surprises.
Bull Case
If Sotera Health meets or exceeds EPS and revenue expectations, it could signal strong operational performance and market demand, potentially leading to a positive stock reaction.
Bear Case
Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its growth trajectory and lead to a negative market reaction.
EPS
$0.17Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.
Revenue
$271MRevenue figures provide insight into the company's sales performance and overall market demand for its services.
Expectations
The print will turn on these two things.
Q1
Will EPS exceed the consensus estimate of $0.17?
A beat on EPS would reinforce the company's strong performance and could lead to a positive stock reaction.
Q2
What guidance will management provide regarding revenue growth?
Management's outlook on revenue growth will be critical in assessing the company's future prospects and market confidence.
Edge
Why consensus could be wrong
The Street may underestimate Sotera Health's ability to maintain high margins despite potential cost pressures, as evidenced by its recent strong EPS performance.
Supporting Evidence
The company has consistently beaten EPS estimates, indicating strong management execution.
Recent trends in the health care sector suggest increasing demand for sterilization services, which could benefit Sotera Health.
The stock's historical performance indicates that it can rebound quickly from temporary setbacks.
Key Risk
If revenue growth comes in below $261M, it could challenge the optimistic outlook currently held by analysts.
Edge
Pre-commit to what would confirm each case.
The market is closely watching how Sotera Health balances profitability with growth, especially after a strong previous quarter.
Bull Confirmed If
Earnings per share of $0.18 or higher would confirm strong operational performance.
Bear Confirmed If
Earnings per share below $0.15 would raise concerns about the company's growth trajectory.
Pre-Earnings Positioning
Implied Move
±4.2%
Historical Avg
±7.3%
The options market is pricing in a moderate move for Sotera Health's stock around the earnings announcement, reflecting uncertainty about the results.
Options are pricing ±5.0% while SHC has averaged ±7.3% over the last 8 prints — setup is pricing cheap.
30d HV
35.9%
Preparation
Likely market behavior by outcome — not investment advice.
Beat & Raise
History suggests that if Sotera Health beats expectations, the stock could rise by an average of 2.03%, confirming strong operational momentum.
In-Line / Cautious
If results are in line with expectations, the market may react cautiously, reflecting uncertainty about future growth.
Miss
If the company misses expectations, history indicates a potential drop of around 7.29%, signaling market disappointment.
Preparation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ARES MGMT CORP Class A